Kathy Oubre on Challenges, Solutions to Addressing Clinical Trial Participation

April 21, 2020

SAP Partners

The clinicians and nurses at Pontchartrain Cancer Center address the education behind the clinical trials, which helps patients understand that they can have access to cutting edge therapy that they would not otherwise have access to, said Kathy W. Oubre, MS, chief operating officer at Pontchartrain Cancer Center. Kathy Oubre is additionally scheduled to speak at the Community Oncology Alliance Virtual Meeting, which runs from April 23-24, 2020.

"Our clinicians and our nurses address the education behind the clinical trials, the ability to, in a lot of cases, have access to cutting edge therapy that they would not otherwise have access to," said Kathy W. Oubre, MS, chief operating officer at Pontchartrain Cancer Center. Kathy Oubre is additionally scheduled to speak at the Community Oncology Alliance Virtual Meeting, which runs from April 23-24, 2020 and can be registered for here.

Transcript

Pontchartrain Cancer Center is located in southeastern Louisiana; what challenges do you face when providing care to patients in this area?

So, you have to first get past the stigma of the patient feeling like a test subject. I think that was very common 10 or 20 years ago. I think clinical trials got a bad reputation from that. We primarily address that through education. Our clinicians and our nurses just address the education behind the clinical trials, the ability to, in a lot of cases, have access to cutting edge therapy that they would not otherwise have access to. Educating them about all of the advances in science and how they might be able to have that hand in changing therapy for themselves and other people coming after them.